NASDAQ

ProShares Ultra Nasdaq Biotechnology (BIB)

♥ 706 Thanks from members

Live price chart, market sentiment, and community perspectives for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Financial ServicesIndustry: Leveraged Exchange Traded FundsFounder: ProSharesLeadership: Michael Sapir (CEO)Leadership: Michael Mundt (President)Holder: Susquehanna International GroupHolder: Citadel AdvisorsHolder: Jane Street GroupProShares Ultra Nasdaq Biotechnology#BIB#ProShares#Nasdaq Biotechnology#Leveraged ETF#Ultra Biotech